| DB ID | MyCo_3912 |
| Title | Mast cell tryptase changes with Aspergillus fumigatus - Host crosstalk in cystic fibrosis patients |
| Year | 2018 |
| PMID | 29456195 |
| Fungal Diseases involved | Aspergillosis |
| Associated Medical Condition | Cystic fibrosis |
| Genus | Aspergillus |
| Species | fumigatus |
| Organism | Aspergillus fumigatus |
| Ethical Statement | Under the French law, ethics committee approval and patient consent were not required for this type of non-interventional study, provided the patients had received information and retained the right to oppose the use of excess serum and anonymized medical data |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Tryptase |
| Biomarker Full Name | Tryptase |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | France |
| Cohort | Seventy-six CF patients were studied. |
| Cohort No. | 76 |
| Age Group | 2–59 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Immunological assay |
| Analysis Method | ImmunoCAP assay |
| ELISA kits | None |
| Assay Data | ImmunoCAP (ThermoFisher Scientific, Uppsala, Sweden) |
| Validation Techniques used | ImmunoCAP assay |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
